{"id":3888,"date":"2017-10-27T07:03:39","date_gmt":"2017-10-27T05:03:39","guid":{"rendered":"https:\/\/www.nanexa.com\/mfn_news\/nanexa-breddar-affarsmojligheterna-med-eget-produktprojekt-inom-onkologiomradet\/"},"modified":"2020-06-26T14:25:57","modified_gmt":"2020-06-26T12:25:57","slug":"nanexa-breddar-affarsmojligheterna-med-eget-produktprojekt-inom-onkologiomradet","status":"publish","type":"mfn_news","link":"https:\/\/nanexa.com\/sv\/mfn_news\/nanexa-breddar-affarsmojligheterna-med-eget-produktprojekt-inom-onkologiomradet\/","title":{"rendered":"Nanexa breddar aff\u00e4rsm\u00f6jligheterna med eget produktprojekt inom onkologiomr\u00e5det."},"content":{"rendered":"<div class=\"mfn-preamble\"><strong>M\u00e5ndagens st\u00e4mmobeslut att g\u00e5 vidare med den av styrelsen f\u00f6reslagna nyemissionen skapar de<\/p>\n<p>finansiella m\u00f6jligheterna f\u00f6r bolaget att p\u00e5b\u00f6rja och driva ett produktprojekt i egen regi.<\/strong><\/div>\n<p>Strategin ut\u00f6kar<\/p>\n<p>m\u00f6jligheterna till framtida int\u00e4kter fr\u00e5n produktlicensiering, samtidigt som projektet succesivt kommer<\/p>\n<p>att ge v\u00e4rdefulla resultat f\u00f6r utlicensieringen av sj\u00e4lva teknologiplattformen PharmaShell\u00ae.<\/p>\n<p>Nanexa har identifierat onkologiomr\u00e5det som s\u00e4rskilt intressant och har redan kontakt med ett antal<\/p>\n<p>experter inom omr\u00e5det. Bolaget siktar p\u00e5 att under f\u00f6rsta halv\u00e5ret 2018 fatta inriktningsbeslut f\u00f6r<\/p>\n<p>projektet om val av specifik indikation och aktiv substans som matchar ett viktigt medicinskt behov och en<\/p>\n<p>betydande marknadspotential. Bolaget avser d\u00e4refter att dokumentera projektet prekliniskt och<\/p>\n<p>f\u00f6rbereda en f\u00f6rsta klinisk studie, att genomf\u00f6ra tillsammans med en partner eller i egen regi.<\/p>\n<p>&#34;De nyligen erh\u00e5llna resultaten b\u00e5de fr\u00e5n utvecklingen av sj\u00e4lva teknologin och de goda<\/p>\n<p>djurstudieresultaten g\u00f6r att vi nu k\u00e4nner oss mogna att ta detta viktiga steg&#34;, s\u00e4ger Nanexas VD David<\/p>\n<p>Westberg.<\/p>\n<p>F\u00f6r ytterligare information:<\/p>\n<p>Nanexa AB (publ)<\/p>\n<p>David Westberg, VD<\/p>\n<p>Tel. 0709-42 83 03<\/p>\n<p>E-mail: david.westberg@nanexa.se<\/p>\n<p>www.nanexa.com<\/p>\n<p>Om Nanexa AB (publ)<\/p>\n<p>Nanexa AB \u00e4r ett nanoteknologiskt drug delivery-f\u00f6retag som fokuserar verksamheten p\u00e5 utvecklingen av<\/p>\n<p>PharmaShell\u00ae som \u00e4r ett nytt och banbrytande drug delivery-system som bed\u00f6ms ha en stor potential inom<\/p>\n<p>ett flertal indikationsomr\u00e5den. Inom ramen f\u00f6r PharmaShell\u00ae har Nanexa samarbetsavtal med bland andra<\/p>\n<p>AstraZeneca.<\/p>\n<div class=\"mfn-footer mfn-attachment\">\n<p><strong>Bifogade filer<\/strong><\/p>\n<hr\/>\n<p><a href=\"http:\/\/mb.cision.com\/Main\/12591\/2377460\/742982.pdf\" target=\"_blank\" rel=\"nofollow noopener noreferrer\"><\/a><\/p>\n<\/div>\n<div class=\"mfn-footer\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>M\u00e5ndagens st\u00e4mmobeslut att g\u00e5 vidare med den av styrelsen f\u00f6reslagna nyemissionen skapar de<\/p>\n<p>finansiella m\u00f6jligheterna f\u00f6r bolaget att p\u00e5b\u00f6rja och driva ett produktprojekt i egen regi.<\/p>\n","protected":false},"template":"","class_list":["post-3888","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-ci_sv","mfn-news-tag-mfn-type-ir_sv","mfn-news-tag-mfn_sv","mfn-news-tag-mfn-ci-other_sv","mfn-news-tag-mfn-lang-sv_sv"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Nanexa breddar aff\u00e4rsm\u00f6jligheterna med eget produktprojekt inom onkologiomr\u00e5det. - Nanexa AB<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nanexa.com\/mfn_news\/nanexa-breddar-affarsmojligheterna-med-eget-produktprojekt-inom-onkologiomradet\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nanexa breddar aff\u00e4rsm\u00f6jligheterna med eget produktprojekt inom onkologiomr\u00e5det. - Nanexa AB\" \/>\n<meta property=\"og:description\" content=\"M\u00e5ndagens st\u00e4mmobeslut att g\u00e5 vidare med den av styrelsen f\u00f6reslagna nyemissionen skapar de finansiella m\u00f6jligheterna f\u00f6r bolaget att p\u00e5b\u00f6rja och driva ett produktprojekt i egen regi.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nanexa.com\/mfn_news\/nanexa-breddar-affarsmojligheterna-med-eget-produktprojekt-inom-onkologiomradet\/\" \/>\n<meta property=\"og:site_name\" content=\"Nanexa AB\" \/>\n<meta property=\"article:modified_time\" content=\"2020-06-26T12:25:57+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/nanexa-breddar-affarsmojligheterna-med-eget-produktprojekt-inom-onkologiomradet\\\/\",\"url\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/nanexa-breddar-affarsmojligheterna-med-eget-produktprojekt-inom-onkologiomradet\\\/\",\"name\":\"Nanexa breddar aff\u00e4rsm\u00f6jligheterna med eget produktprojekt inom onkologiomr\u00e5det. - Nanexa AB\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#website\"},\"datePublished\":\"2017-10-27T05:03:39+00:00\",\"dateModified\":\"2020-06-26T12:25:57+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/nanexa-breddar-affarsmojligheterna-med-eget-produktprojekt-inom-onkologiomradet\\\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/nanexa-breddar-affarsmojligheterna-med-eget-produktprojekt-inom-onkologiomradet\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/nanexa-breddar-affarsmojligheterna-med-eget-produktprojekt-inom-onkologiomradet\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Hem\",\"item\":\"https:\\\/\\\/nanexa.com\\\/sv\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MFN News Items\",\"item\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Nanexa breddar aff\u00e4rsm\u00f6jligheterna med eget produktprojekt inom onkologiomr\u00e5det.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#website\",\"url\":\"https:\\\/\\\/nanexa.com\\\/\",\"name\":\"Nanexa AB\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nanexa.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\",\"name\":\"Nanexa AB\",\"url\":\"https:\\\/\\\/nanexa.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nanexa.com\\\/wp-content\\\/uploads\\\/2015\\\/04\\\/nanexa-logo.png\",\"contentUrl\":\"https:\\\/\\\/nanexa.com\\\/wp-content\\\/uploads\\\/2015\\\/04\\\/nanexa-logo.png\",\"width\":165,\"height\":50,\"caption\":\"Nanexa AB\"},\"image\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nanexa breddar aff\u00e4rsm\u00f6jligheterna med eget produktprojekt inom onkologiomr\u00e5det. - Nanexa AB","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nanexa.com\/mfn_news\/nanexa-breddar-affarsmojligheterna-med-eget-produktprojekt-inom-onkologiomradet\/","og_locale":"sv_SE","og_type":"article","og_title":"Nanexa breddar aff\u00e4rsm\u00f6jligheterna med eget produktprojekt inom onkologiomr\u00e5det. - Nanexa AB","og_description":"M\u00e5ndagens st\u00e4mmobeslut att g\u00e5 vidare med den av styrelsen f\u00f6reslagna nyemissionen skapar de finansiella m\u00f6jligheterna f\u00f6r bolaget att p\u00e5b\u00f6rja och driva ett produktprojekt i egen regi.","og_url":"https:\/\/nanexa.com\/mfn_news\/nanexa-breddar-affarsmojligheterna-med-eget-produktprojekt-inom-onkologiomradet\/","og_site_name":"Nanexa AB","article_modified_time":"2020-06-26T12:25:57+00:00","twitter_card":"summary_large_image","twitter_misc":{"Ber\u00e4knad l\u00e4stid":"1 minut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/nanexa.com\/mfn_news\/nanexa-breddar-affarsmojligheterna-med-eget-produktprojekt-inom-onkologiomradet\/","url":"https:\/\/nanexa.com\/mfn_news\/nanexa-breddar-affarsmojligheterna-med-eget-produktprojekt-inom-onkologiomradet\/","name":"Nanexa breddar aff\u00e4rsm\u00f6jligheterna med eget produktprojekt inom onkologiomr\u00e5det. - Nanexa AB","isPartOf":{"@id":"https:\/\/nanexa.com\/#website"},"datePublished":"2017-10-27T05:03:39+00:00","dateModified":"2020-06-26T12:25:57+00:00","breadcrumb":{"@id":"https:\/\/nanexa.com\/mfn_news\/nanexa-breddar-affarsmojligheterna-med-eget-produktprojekt-inom-onkologiomradet\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nanexa.com\/mfn_news\/nanexa-breddar-affarsmojligheterna-med-eget-produktprojekt-inom-onkologiomradet\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/nanexa.com\/mfn_news\/nanexa-breddar-affarsmojligheterna-med-eget-produktprojekt-inom-onkologiomradet\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Hem","item":"https:\/\/nanexa.com\/sv\/"},{"@type":"ListItem","position":2,"name":"MFN News Items","item":"https:\/\/nanexa.com\/mfn_news\/"},{"@type":"ListItem","position":3,"name":"Nanexa breddar aff\u00e4rsm\u00f6jligheterna med eget produktprojekt inom onkologiomr\u00e5det."}]},{"@type":"WebSite","@id":"https:\/\/nanexa.com\/#website","url":"https:\/\/nanexa.com\/","name":"Nanexa AB","description":"","publisher":{"@id":"https:\/\/nanexa.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nanexa.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"},{"@type":"Organization","@id":"https:\/\/nanexa.com\/#organization","name":"Nanexa AB","url":"https:\/\/nanexa.com\/","logo":{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/nanexa.com\/#\/schema\/logo\/image\/","url":"https:\/\/nanexa.com\/wp-content\/uploads\/2015\/04\/nanexa-logo.png","contentUrl":"https:\/\/nanexa.com\/wp-content\/uploads\/2015\/04\/nanexa-logo.png","width":165,"height":50,"caption":"Nanexa AB"},"image":{"@id":"https:\/\/nanexa.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/mfn_news\/3888","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/media?parent=3888"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}